darzalex 100 mg per 5 ml concentrate for solution for infusion
janssen pharmaceutica n.v, belgium - daratumumab - concentrate for solution for infusion - 20 mg/ml
darzalex 400 mg per 20 ml concentrate for solution for infusion
janssen pharmaceutica n.v, belgium - daratumumab - concentrate for solution for infusion - 20 mg/ml
cyramza 10 mg/ml injection
eli lilly and company, united states - ramucirumab - injection - 10 mg/ml
cyramza 10 mg/ml injection
eli lilly and company, united states - ramucirumab - injection - 10 mg/ml
tecentriq concentrate for solution for infusion
f. hoffmann-la roche ltd. 4303 kaiseraugst- secondary packager - atezolizumab - concentrate for solution for infusion - 60mg/ml
tecentriq concentrate for solution for infusion
f. hoffmann-la roche ltd. - atezolizumab - concentrate for solution for infusion - 60mg/ml
besponsa lyophilizate for concentrate for solution for infusion
pharmacia and upjohn company - inotuzumab ozogamicin - lyophilizate for concentrate for solution for infusion - 1mg
keytruda 25 mg/ml concentrate for solution for infusion
merck sharp & dohme, united kingdom - pembrolizumab - concentrate for solution for infusion - 25 mg/ml
empliciti 300 mg lyphoilisate for solution for infusion powder for concentrate for solution for infusion
bristol-myers squibb, united states - elotuzumab - powder for concentrate for solution for infusion - 300 mg
empliciti 400 mg lyphoilisate for solution for infusion powder for concentrate for solution for infusion
bristol-myers squibb, united states - elotuzumab - powder for concentrate for solution for infusion - 400 mg